Fractional Yellow Fever Vaccine in Rheumatic Diseases

Open-label trial of 17D yellow fever vaccine in yellow fever (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoints: Number of participants with severe adverse events to the fractional dose of Yellow Fever vaccine at 10 days and Number of participants with protective levels of antibodies against Yellow Fever vaccine at 30 days. Started Jan 2018; status: completed.